Vis enkel innførsel

dc.contributor.authorNorum, Martin
dc.contributor.authorRisvang, Linn
dc.contributor.authorBjørnsen, Thomas
dc.contributor.authorDimitriou, Lygeri
dc.contributor.authorRønning, Per Ola
dc.contributor.authorBjørgen, Morten
dc.contributor.authorRaastad, Truls
dc.date.accessioned2021-02-02T12:02:59Z
dc.date.available2021-02-02T12:02:59Z
dc.date.created2020-07-20T21:11:54Z
dc.date.issued2020
dc.identifier.citationScandinavian Journal of Medicine & Science in Sports. 2020, 30(11), 2116-2129.en_US
dc.identifier.issn0905-7188
dc.identifier.urihttps://hdl.handle.net/11250/2725795
dc.descriptionThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_US
dc.description.abstractThe effects of 4 mg·kg−1caffeine ingestion on strength and power were investigated for the first time, in resistance‐trained females during the early follicular phase utilizing a randomized, double‐blind, placebo‐controlled, crossover design. Fifteen females (29.8 ± 4.0 years, 63.8 ± 5.5 kg [mean ± SD]) ingested caffeine or placebo 60 minutes before completing a test battery separated by 72 hours. One‐repetition maximum (1RM), repetitions to failure (RTF) at 60% of 1RM, was assessed in the squat and bench press. Maximal voluntary contraction torque (MVC) and rate of force development (RFD) were measured during isometric knee extensions, while utilizing interpolated twitch technique to measure voluntary muscle activation. Maximal power and jump height were assessed during countermovement jumps (CMJ). Caffeine metabolites were measured in plasma. Adverse effects were registered after each trial. Caffeine significantly improved squat (4.5 ± 1.9%, effect size [ES]: 0.25) and bench press 1RM (3.3 ± 1.4%, ES: 0.20), and squat (15.9 ± 17.9%, ES: 0.31) and bench press RTF (9.8 ± 13.6%, ES: 0.31), compared to placebo. MVC torque (4.6 ± 7.3%, ES: 0.26), CMJ height (7.6 ± 4.0%, ES: 0.50), and power (3.8 ± 2.2%, ES: 0.24) were also significantly increased with caffeine. There were no differences in RFD or muscle activation. Plasma [caffeine] was significantly increased throughout the protocol, and mild side effects of caffeine were experienced by only 3 participants. This study demonstrated that 4 mg·kg−1 caffeine ingestion enhanced maximal strength, power, and muscular endurance in resistance‐trained and caffeine‐habituated females during the early follicular phase, with few adverse effects. Female strength and power athletes may consider using this dose pre‐competition and ‐training as an effective ergogenic aid.en_US
dc.language.isoengen_US
dc.subjectcaffeine supplementationen_US
dc.subjectfemale athletesen_US
dc.subjectmuscular activation levelen_US
dc.subjectmuscular enduranceen_US
dc.subjectstrength and power performanceen_US
dc.titleCaffeine Increases Strength and Power Performance in Resistance-trained Females During Early Follicular Phaseen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 The Authors.en_US
dc.source.journalScandinavian Journal of Medicine & Science in Sportsen_US
dc.identifier.doi10.1111/sms.13776
dc.identifier.cristin1819947
dc.description.localcodeInstitutt for fysisk prestasjonsevne / Department of Physical Performanceen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel